Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Sarah Parisi & Carlo Finelli. (2021) Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients. Journal of Blood Medicine 12, pages 1019-1030.
Read now
Read now
Lap Shu Alan Chan, Roman Shapiro, Rena Buckstein, Yulia Lin, Jeannie Callum, Lisa Chodirker, Christina D. Lee, Anca Prica, Adam Lam, Alexandre Mamedov & Richard A. Wells. (2014) Initial transfusion intensity predicts survival in myelodysplastic syndrome. Leukemia & Lymphoma 55:10, pages 2296-2300.
Read now
Read now
Shucheng Gu, Xiaoli Song, Youshan Zhao, Juan Guo, Chengming Fei, Feng Xu, Lingyun Wu, Xi Zhang, Jungong Zhao, Chunkang Chang & Xiao Li. (2013) The Evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes. Hematology 18:5, pages 286-294.
Read now
Read now
Mhairi Mitchell, Steven D Gore & Amer M Zeidan. (2013) Iron chelation therapy in myelodysplastic syndromes: where do we stand?. Expert Review of Hematology 6:4, pages 397-410.
Read now
Read now
Batsirai Mutetwa, Jon Fryzek, Yan Du, Mellissa Yong, Mikkael A. Sekeres & Emanuela Taioli. (2011) Baseline characteristics and predictors of outcome in patients with myelodysplastic syndromes living in Western Pennsylvania. Leukemia & Lymphoma 52:2, pages 265-272.
Read now
Read now
Lisa Chodirker & Richard A Wells. (2009) Iron overload in myelodysplastic syndromes. Expert Review of Hematology 2:3, pages 215-218.
Read now
Read now
Articles from other publishers (25)
Diego Hernando, Rachel J. Cook, Naila Qazi, Colin A. Longhurst, Carol A. Diamond & Scott B. Reeder. (2020) Complex confounder-corrected R2* mapping for liver iron quantification with MRI. European Radiology 31:1, pages 264-275.
Crossref
Crossref
Francesca Vinchi, Saskia Hell & Uwe Platzbecker. (2020) Controversies on the Consequences of Iron Overload and Chelation in MDS. HemaSphere 4:3, pages e357.
Crossref
Crossref
Jiaxin Hu, Fanqiao Meng, Xian Hu, Lei Huang, Hui Liu, Zhaoyun Liu & Lijuanli Li. (2020) Iron overload regulate the cytokine of mesenchymal stromal cells through ROS/HIF-1α pathway in Myelodysplastic syndromes. Leukemia Research 93, pages 106354.
Crossref
Crossref
Qingqing Zheng, Youshan Zhao, Juan Guo, Sida Zhao, Chengming Fei, Chao Xiao, Dong Wu, Lingyun Wu, Xiao Li & Chunkang Chang. (2018) Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway. Cell Death & Disease 9:5.
Crossref
Crossref
Annekathrin Hilken, Claudia Langebrake, Christine Wolschke, Jan Felix Kersten, Holger Rohde, Peter Nielsen & Nicolaus Kr?ger. (2017) Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT). Annals of Hematology 96:8, pages 1379-1388.
Crossref
Crossref
Qing-qing Zheng, You-shan Zhao, Juan Guo, Si-da Zhao, Lu-xi Song, Cheng-ming Fei, Zheng Zhang, Xiao Li & Chun-kang Chang. (2017) Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome. Leukemia Research 58, pages 55-62.
Crossref
Crossref
Tatiana Araujo Pereira, Gisele Espinha Teixeira da Silva, Raúl Bonne Hernández, Fabio Luis Forti & Breno Pannia Espósito. (2013) Antitumor activity of Mn(III) complexes in combination with phototherapy and antioxidant therapy. BioMetals 26:3, pages 439-446.
Crossref
Crossref
Rebecca L.C. Adams & Robert J. Bird. (2013) Safety and efficacy of deferasirox in the management of transfusion-dependent patients with myelodysplastic syndrome and aplastic anaemia: a perspective review. Therapeutic Advances in Hematology 4:2, pages 93-102.
Crossref
Crossref
Yelena Z. Ginzburg & Beth H. Shaz. 2013. Transfusion Medicine and Hemostasis. Transfusion Medicine and Hemostasis
449
451
.
Meghna Patel & D. V. S. S. Ramavataram. (2012) Non Transferrin Bound Iron: Nature, Manifestations and Analytical Approaches for Estimation. Indian Journal of Clinical Biochemistry 27:4, pages 322-332.
Crossref
Crossref
Shohei Kikuchi, Masayoshi Kobune, Satoshi Iyama, Tsutomu Sato, Kazuyuki Murase, Yutaka Kawano, Kohichi Takada, Kaoru Ono, Yumiko Kaneko, Koji Miyanishi, Yasushi Sato, Tsuyoshi Hayashi, Rishu Takimoto & Junji Kato. (2012) Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox. Free Radical Biology and Medicine 53:4, pages 643-648.
Crossref
Crossref
Sharif Ali, Jason D. Pimentel, Javier Munoz, Veena Shah, Rick McKinnon, George Divine & Nalini Janakiraman. (2012) Iron Overload in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Archives of Pathology & Laboratory Medicine 136:5, pages 532-538.
Crossref
Crossref
Shohei Kikuchi, Masayoshi Kobune, Satoshi Iyama, Tsutomu Sato, Kazuyuki Murase, Yutaka Kawano, Kohichi Takada, Kaoru Ono, Tsuyoshi Hayashi, Koji Miyanishi, Yasushi Sato, Rishu Takimoto & Junji Kato. (2012) Prognostic significance of serum ferritin level at diagnosis in myelodysplastic syndrome. International Journal of Hematology 95:5, pages 527-534.
Crossref
Crossref
L. B. Jordan, F. Vekeman, A. Sengupta, M. Corral, A. Guo & M. S. Duh. (2012) Persistence and compliance of deferoxamine versus deferasirox in Medicaid patients with sickle-cell disease. Journal of Clinical Pharmacy and Therapeutics 37:2, pages 173-181.
Crossref
Crossref
Pierre Brissot, Martine Ropert, Caroline Le Lan & Olivier Lor?al. (2012) Non-transferrin bound iron: A key role in iron overload and iron toxicity. Biochimica et Biophysica Acta (BBA) - General Subjects 1820:3, pages 403-410.
Crossref
Crossref
Mayara Marinovic Baccan, Orlando Chiarelli-Neto, Regina Mara Silva Pereira & Breno Pannia Espósito. (2012) Quercetin as a shuttle for labile iron. Journal of Inorganic Biochemistry 107:1, pages 34-39.
Crossref
Crossref
Robert E. Fleming & Prem Ponka. (2012) Iron Overload in Human Disease. New England Journal of Medicine 366:4, pages 348-359.
Crossref
Crossref
Stefano Rivella. 2012. Iron Physiology and Pathophysiology in Humans. Iron Physiology and Pathophysiology in Humans
321
341
.
Zvi RappoportAntonello Mai. 2010. Patai's Chemistry of Functional Groups. Patai's Chemistry of Functional Groups.
Douglas B. Kell. (2010) Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples. Archives of Toxicology 84:11, pages 825-889.
Crossref
Crossref
Alan F. List. (2010) Iron Overload in Myelodysplastic Syndromes: Diagnosis and Management. Cancer Control 17:1_suppl, pages 2-8.
Crossref
Crossref
Radha Raghupathy, Deepa Manwani & Jane A. Little. (2010) Iron Overload in Sickle Cell Disease. Advances in Hematology 2010, pages 1-9.
Crossref
Crossref
Anastasios Raptis, Mei Sheng Duh, Si-Tien Wang, Ellison Dial, Ilias Fanourgiakis, Barry Fortner, Carole Paley, Nikita Mody-Patel, Mitra Corral & Jeffrey Scott. (2010) Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices. Transfusion 50:1, pages 190-199.
Crossref
Crossref
R.H.B. Meyboom. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
425
435
.
Richard Stone. (2008) Elevated serum ferritin in patients with a myelodysplastic syndrome: How much of a problem?. American Journal of Hematology 83:8, pages 609-610.
Crossref
Crossref